Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Viva Biotech Holdings ?
1
High Debt company with Weak Long Term Fundamental Strength
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 1.66% signifying low profitability per unit of shareholders funds
2
Flat results in Dec 25
- INVENTORY TURNOVER RATIO(HY) Lowest at 3.51 times
- DEBTORS TURNOVER RATIO(HY) Lowest at 3.03 times
- NET PROFIT(Q) Fallen at -54.63%
3
Below par performance in long term as well as near term
- Along with generating -16.27% returns in the last 1 year, the stock has also underperformed Hang Seng Hong Kong in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Viva Biotech Holdings for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Viva Biotech Holdings
-16.27%
2.02
72.45%
Hang Seng Hong Kong
8.76%
0.45
19.63%
Quality key factors
Factor
Value
Sales Growth (5y)
36.46%
EBIT Growth (5y)
29.19%
EBIT to Interest (avg)
1.98
Debt to EBITDA (avg)
2.22
Net Debt to Equity (avg)
0.08
Sales to Capital Employed (avg)
0.35
Tax Ratio
24.92%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
4.47%
ROE (avg)
1.66%
Valuation Key Factors 
Factor
Value
P/E Ratio
28
Industry P/E
Price to Book Value
1.20
EV to EBIT
21.67
EV to EBITDA
11.05
EV to Capital Employed
1.19
EV to Sales
2.70
PEG Ratio
0.18
Dividend Yield
NA
ROCE (Latest)
5.51%
ROE (Latest)
4.23%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Movement
5What is working for the Company
ROCE(HY)
Highest at 5.6%
DEBT-EQUITY RATIO
(HY)
Lowest at 4.98 %
RAW MATERIAL COST(Y)
Fallen by -7.58% (YoY
-4What is not working for the Company
INVENTORY TURNOVER RATIO(HY)
Lowest at 3.51 times
DEBTORS TURNOVER RATIO(HY)
Lowest at 3.03 times
NET PROFIT(Q)
Fallen at -54.63%
Here's what is working for Viva Biotech Holdings
Debt-Equity Ratio
Lowest at 4.98 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by -7.58% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Viva Biotech Holdings
Net Profit
Fallen at -54.63%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (HKD MM)
Inventory Turnover Ratio
Lowest at 3.51 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Debtors Turnover Ratio
Lowest at 3.03 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio






